Good news for a change
In addition to mRNA vaccines and CAR-T cell therapy, semaglutides and tirzepatides offer transformative therapies, in this case for obesity and associated type-2 diabetes. But the drugs aren’t cheap, so access is a problem in the US. “Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President […]